Top Three Companies in Cancer Vaccine Development

Moderna's breakthrough highlights a competitive field where several biopharma giants are actively developing cancer vaccines, focusing on different technologies and cancer types.

The top 3

1. Leading Developers Beyond Moderna: Besides Moderna, key players in the cancer vaccine market include Merck & Co., BioNTech, and GlaxoSmithKline (GSK), with many forming strategic partnerships to advance their pipelines.
2. Diverse Types of Cancer Vaccines in Development: Cancer vaccines are broadly categorized into preventive and therapeutic types, with therapeutic vaccines further including cell-based, peptide/protein-based, and gene- (DNA/RNA) based approaches, often targeting neoantigens.
3. Top Cancers Targeted by Vaccine Trials: A wide range of cancers are being targeted in vaccine clinical trials, with non-small cell lung cancer, melanoma, breast cancer, colorectal cancer, and pancreatic cancer among the most common.

Open the full topic